Goldie A. Kurtz, MD

Radiation Oncology
Accepting new patients
Sees patients of all ages
Penn Radiation Oncology Perelman - 2nd Floor
Penn Medicine Provider

About me

  • Associate Professor of Clinical Radiation Oncology

My education and training

  • Residency: University of Toronto Affiliated Hospitals

Spoken languages

English
English

Reviews

Average Rating

334 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
July 2026
she's awesome
Anonymous
July 2026
thorough, knowledgeable and kind. explains clearly.
Anonymous
July 2026
she is truly caring & a great dr
Anonymous
June 2026
provider is professional, courteous n caring. makes a difference in treatment n positivity all around.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kurtz is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Rupesh Kotecha, Veronica Chiang, Martin C Tom, Ephraim Parent, Ali Nabavizadeh, Barry A Siegel, Jiayi Huang, Elcin Zan, Srinivas Peddi, Steven Brem, Marcus Ware, Erik P Sulman, Santosh Kesari, Whitney Pope, Robin Holmes, Albert Chau, Eugene J Teoh, Samuel T Chao, Mariam Aboian; PURSUE Study Group:Marissa Barbaro, Surya Chundru, Stephen Fogelson, Manu S Goyal, Albert H Kim, Douglas Kondziolka, Goldie Kurtz, Mary Lokuta, Minesh P Mehta, Matthew P Miller, Yazmin Odia, Maria Rosana Ponisio, Sharon Weick 18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study , Int J Radiat Biol Phys., 25(5): 2026


Linkowski L, Messing I, Berger M, Hollawell C, Friedes C, Alexander D, Wang X, Desai AS, Phillips RE, O'Rourke DM, Amankulor NM, Jackson C, Hubbeling H, Kurtz G, Bagley SJ, Bradley JD, Mohan S, Alonso-Basanta M, Lebow ES Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series. , Int J Radiat Oncol Biol Phys: 2026,Online ahead of print.


Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ. Feasibility and Safety of High Dose Proton Re-irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single Institution Retrospective Study. , Pediatric Blood Cancer: 2026


Akbari H, Mohan S, Liu F, Jiang C, Fathi Kazerooni A, Berger M, Rathore S, Bilello M, Sako C, Garcia J, Brem S, Bakas S, Mamourian E, Pepin A, James P, Dorsey J, Singh A, Parker D, Verma R, Cao Q, Bagley SJ, Desai A, O'Rourke DM, Shinohara RT, Nasrallah MP, Teo BK, Kurtz G, Shukla G, Alonso-Basanta M, Lustig RA, Davatzikos C. Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study. , Nat Commun, 17(1): 2026


Friedes C, Berger M, Linkowski L, Hollawell C, Hubbeling H, Alexander D, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Brem S, Davatzikos C, Nasrallah M, O'Rourke DM, Jackson C, Amankulor NM, Alonso-Basanta M, Mohan S, Bagley SJ, Lebow ES. Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study , J Neurooncology, 177(3): 2026


Messing I, Linkowski L, Riina MD, Berger M, Baron J, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Kurtz G, Nagda S, Lukens JN, Flowers A, Lee JYK, Amankulor NM, Jackson C, Mohan S, Amaravadi RK, Schuchter LM, Huang AC, Mitchell TC, Alonso-Basanta M, Lebow ES. Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy , Oncologist, 31(4): 2026


Jiang C, McWilliams T, Berger M, Lebow ES, Hubbeling H, Azar E, Kolker JD, Nagda SN, Kurtz G, Zou JW, Scheuermann R, Kumar A, Alonso-Basanta M. Periventricular Radionecrosis after Conventionally Fractionated Radiation for Low Grade Meningiomas , Radiation Oncology, 20(1): 2025


Melanie Berger, Cole Friedes, Lauren Linkowski, Casey Hollawell, Harper Hubbeling, Robert Lustig, Goldie Kurtz, Jay Dorsey, Arati Desai, Richard Phillips, MacLean Nasrallah, Ali Nabavizadeh, Steven Brem, John Lee, Donald O'Rourke, Nduka Amankulor, Steven Bagley, Suyash Mohan, Michelle Alonso-Basanta, Emily Lebow Clinical and Dosimetric Predictors of Severe Radiation-Induced Lymphopenia in Patients with Newly Diagnosed IDH-Wildtype High Grade Glioma Undergoing Adjuvant Radiotherapy , American Society of Radiation Oncology (ASTRO) Annual Meeting: 2025


Goldie A Kurtz, Anusha Kalbasi, Brett Hartl, Bridget Bieda, Uri Amit, Michelle Alonso-Basanta, Michael J LaRiviere, Christine E Hill-Kayser Life-Threatening Malignancy in Pregnancy: A Case Series of Three Patients Treated with Proton Radiotherapy with Long Term Follow-up. , Canadian Associate of Radiation Oncology, Annual Meeting 2025: 2025


Matthew Riina, Emily Lebow, Yoshiya Yamada, Jessica Wilcox, Luke Pike, Brandon Imber, Ian Messing, Robert Lustig, Harper Hubbeling, Goldie Kurtz, Michelle Alonso-Basanta, Andrew Seidman, Elena Pentsova, Helena Yu, Mark Kris, Nelson Moss, Jonathan Yang, Adrienne Boire, Yao Yu Proton Craniospinal Radiation for Leptomeningeal Disease from Patients with Metastatic Solid Tumors: A Multi-Institutional Retrospective Analysis , American Society of Radiation Oncology (ASTRO) Annual Meeting: 2025